Diabetes: Diabetes therapy and cancer risk

Nature Reviews Endocrinology

Volumn 5, Issue 12, 2009, Pages 651-652

  Vigneri, Riccardo ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; HUMAN INSULIN; INSULIN ASPART; INSULIN GLARGINE; INSULIN LISPRO; METFORMIN;

CANCER INCIDENCE; CANCER RISK; DIABETES MELLITUS; DRUG EFFECT; DRUG SAFETY; HUMAN; HYPERINSULINEMIA; METABOLIC REGULATION; PRIORITY JOURNAL; SHORT SURVEY;

DIABETES MELLITUS; HUMANS; HYPOGLYCEMIC AGENTS; NEOPLASMS; RISK FACTORS;

EID: 70749092381     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2009.219     Document Type: Short Survey

References (10)

1. Hemkens, L. G. et al. Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study. Diabetologia 52, 1732-1744 (2009).
2. Libby, G. et al. New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes. Diabetes Care 32, 1620-1625 (2009).
3. Vigneri, P, Frasca, E, Sciacca, L., Pandini, G. & Vigneri, R. Diabetes and cancer. Endocr. Relat Cancer doi:10.1677/ERCO9O087.
4. Kurtzhals,P.etal. Correlationsofreceptorbindingandmetabolicandmitogenicpotenciesofinsulinanalogs designedforclinicaluse.Diabetes49,999-1005(2000).(Pubitemid30349423)
5. Hansen, B. F. Insulin analogues with increased mitogenic potency - are they safe? Horm. Metab. Res. 40, 431-433 (2008).
6. Jonasson, J. M. et al. Insulin glargine use and short-term incidence of malignancies-a population-based follow-up study in Sweden. Diabetologia 52, 1745-1754 (2009).
7. Colhoun, H. M. et al. Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetologia 52, 1755-1765 (2009).
8. Currie, C. J., Poole, C. D. & Gale, E. A. The influence of glucose-lowering therapies on cancer risk in type 2 diabetes. Diabetologia 52, 1766-1777 (2009).
9. Vigneri, P., Frasca, F., Sciacca, L., Frittitta, L. & Vigneri, R. Obesity and cancer. Nutr. Metab. Cardiovasc Dis. 16, 1-7 (2006).
10. Nathan, D. M. et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorhythm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 32,193-203 (2009).